Oct 7 2014
Make no bones about it; post-menopausal women are well aware of the risks of brittle bones and fractures; however, a national survey of women taken for AIDP, Inc., the supplier of KoACT®, a patented combination of collagen and calcium, found that almost half (49%) are not taking any bone health supplement to address this major health issue. And, even fewer are not aware of the newest science supporting that a calcium-collagen combination is optimal for bone health.
Highlights of the survey include:
•93% of the women polled were aware of the role of calcium plays in bone health.
•Less than half, 49%, of respondents are now taking a bone health nutritional supplement.
•42% had read or heard something recently about the role of collagen, a critical factor in bone health.
•35% responded that a peer-reviewed and published journal article describing the how collagen and calcium works to protect bones would influence their choice in supplements
Kathy Lund, vice president of marketing and business development, said, "The KoACT survey shows that women 'get it' when it comes to understanding the relationship between menopause and bone health; but half are not taking the right steps to achieve optimal bone health. Most importantly, knowledge is lagging behind scientific developments. Almost a decade of rigorous science demonstrates that collagen and calcium are the 'dynamic duo,' the best for you, answer; yet, surprisingly 42% of those polled had heard something recently about collagen.
"AIDP has invested in calcium and collagen research and produced a breakthrough ingredient, KoACT, a new solution for bone health addressing the complete bone matrix. Once women understand they need a specific blend of collagen and calcium, like KoACT, to strengthen and rebuild bone health, they will demand new products," she added.
Osteoporosis is a major public health threat for an estimated 44 million Americans or 55 percent of the people 50 years of age and older. In the U.S. today, eight million women and two million men are estimated to already have the disease and almost 34 million more are estimated to have low bone mass, placing them at increased risk for osteoporosis.